Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Dashori 100mg Tablet
Manufacturer/Marketed By : TORRENT PHARMACEUTICALS LTD
$80.86 $48.52
Dashori 100mg Tablet consists of the active ingredient Dasatinib. It is prescribed for adults and children above one year of age with Chronic Myeloid Leukemia. This medicine is used to...
DASATINIB
Active Pharmaceutical Ingredient
Dashori 100mg Tablet
$80.86
$48.52
Dashori 100mg Tablet consists of the active ingredient Dasatinib. It is prescribed for adults and children above one year of age with Chronic Myeloid Leukemia. This medicine is used to treat newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukaemia (CML) in the chronic phase and Ph+ acute lymphoblastic leukaemia in patients resistant to other therapies. Chronic Myeloid Leukemia refers to a type of blood cancer that makes the body produce too many white blood cells that happen due to alteration in the Philadelphia chromosome. Acute Lymphoblastic Leukemia is the most common form of blood cancer that affects children. In this case, the lymphocytes of white blood cells multiply too quickly and live too long. The common side effects that are likely to be associated with Dashori 100mg Tablet are diarrhoea, headache, cough, rash, nausea, tiredness, vomiting, muscle pain, weakness, low appetite, and high or low blood pressure. Inform your doctor if these side effects disturb or persist in you. Inform your doctor if you are allergic to Dasatinib and its ingredients. Before starting treatment with this medication, you should let your physician know if you have liver or heart problems, breathing difficulties, chest pain, cough, hepatitis B infection, or bleeding problems. This medicine could cause a severe reduction in the number of platelets, WBC or RBC in the blood. Ensure that your physician monitors your blood levels at regular intervals. Tell your healthcare professional about all the medicines you take, including prescription and over-the-counter medicines, vitamins, antacids, and herbal supplements. It is not recommended for children below one year of age.
Active Pharmaceutical Ingredient
Uses
• Children and adults with chronic myeloid leukaemia.
• Adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL) with resistance to prior therapy.
Benefits
Dashori 100mg Tablet works by preventing the abnormal protein from signalling the growth of cancer cells. This aids in preventing or reducing the spread of cancer cells.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Most Common Side Effects
• Diarrhea
• Headache
• Cough
• Rash
• Nausea, tiredness, vomiting
• Muscle pain, weakness
• Low appetite
• High or low BP
Common Side Effects
• Unusual bleeding or bruising
• Rapid heart rate
• Changes in consciousness or speech
• Breathlessness and swelling all over the body
• Fever or signs of infection
• Fluid retention
• Heart problems
• Myelosuppression
• Severe allergic reaction
How To Use
Take the tablet with or without food at the same time each day.
Safety Advice
• Breast Feeding: It is not recommended to breastfeed while taking Dashori 100mg Tablet as it is not known whether this medication passes into breast milk. You should not breastfeed during treatment and for 2 weeks after your final dose.
• Alcohol: It is not known whether it is safe to consume alcohol with Dashori 100mg Tablet. Consult your doctor for advice.
• Liver: Inform your physician before starting this treatment if you have liver disease.
• Lungs: It is unknown whether Dashori 100mg Tablet is safe to administer in patients with lung problems. Inform your physician if you have any lung disease before starting the treatment.
• Driving: It is not known whether it is safe to drive while in treatment with Dashori 100mg Tablet. Consult your doctor for advice.
• Pregnancy: Dashori 100mg Tablet is not recommended for use during pregnancy unless clearly necessary. Your physician will discuss the potential risks during pregnancy. Women should use effective birth control during treatment and 30 days after the final dose.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.



